Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,068.80down ₹28.70 (2.62%)BSE ₹1,069.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,097.50.
30 Oct: open ₹1,050.00, high ₹1,076.90, low ₹972.00
52-week range of traded prices to 30 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,851 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.47%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,77,98551.0% delivered
Strides Pharma Science orders, deals and press releases
485 filed, newest first. Page 10 of 10.
Apr 2008
28 Apr · Business
Press release dated April 28, 2008, titled "Strides Arcolab Q1 08 Global Revenues Grow to Rs.278 crores (USD 69.50 million); PAT of Rs.52.60 crores (USD 13.15 million); Results in line with Guidance". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Business
Press release dated April 24, 2008, titled "Strides Arcolab receives 2 ANDA approvals for Ondansetron Injection USP, 2 mg/ml (20 ml vials) and 2 mg/ml (2 ml vials)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
19 Mar · Business
Press release dated March 19, 2008, titled "Strides Arcolab receives its third injectable ANDA approval for Fosphenytoin Injection 50mg/mL". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Business
Vide its letter dated March 12, 2008 regarding a press release dated March 11, 2008, titled "Strides Arcolab receives USFDA approval for its Penicillin Sterile Facility in Bangalore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Business
Press release dated March 12, 2008, titled "Strides Arcolab receives its second injectable ANDA approval for Tobramycin 40 mg/ mL". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Business
Press release dated March 12, 2008, titled "Strides Arcolab receives Health Canada approval for Tazo Pip Injection". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Mar · Business
Strides Arcolab Limited had informed the Exchange on March 11, 2008 that: "Further to the press release issued by the Company on March 05, 2008 on the closure of Aspen transaction, the Strides Aspen JV today announced the following clarifications: (1) Mr. V Madhusudhan will be CEO of Cellofarm - the Brazilian operation of the JV and Regional Director of the Latin American operations for the JV. Mr. V. Madhusudhan will be appointed to the Board of Strides Aspen JV and will report to the Board of Directors of the JV Company. (2) Mr. Praveen Venkataramanan will lead the rest of the Latin America and Mexico Operations and will report into Mr. V. Madhusudhan." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Mar · Business
Press release dated March 07, 2008, titled "Strides Arcolab FY 07 Global Revenues Grow To Rs.8648 million ( US$ 216 million)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Mar · Business
Press release dated March 05, 2008, titled "Strides Arcolab-India and Aspen-South Africa Announce Successful Completion of the Latin American Transaction". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
8 Feb · Business
Press release dated February 08, 2008, titled "Strides Arcolab, India and Genepharm, Australia Enter Into A Broad and Strategic Partnership For The Australasian Markets Through A Series of Transactions". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
9 Jan · Business
Press release dated January 09, 2008, titled "Strides Arcolab discontinues manufacturing operations in its New Jersey facility". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
20 Nov · Business
Press release, titled "Strides Arcolab, India and Aspen, South Africa enter into a broad and Strategic Partnership through a Series of Transactions". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Nov · Business
Press release dated October 30, 2007, titled "Sagent Pharmaceuticals Inc. and Strides Arcolab Limited Announce Collaboration to Develop and Market Over 25 Products in the U.S ". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
30 Oct · Business
Vide its letter dated October 30, 2007 that: "The Board of Directors at its meeting held today has in-principle approved the proposal for the amalgamation of its wholly owned subsidiaries Quantum Life Sciences Private Limited and Medgene Pharmaceuticals Private Limited, with the Company. The scheme will be subject to all requisite permissions, sanctions and approvals as may be required."30 Oct · Business
Press release dated October 30, 2007, titled "Strides Arcolab registers 19% growth in Sales in Q3 FY07; Revenues at Rs.218 Crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
Aug 2007
8 Aug · Business
Press release dated August 08, 2007, titled "Strides Arcolab receives Health Canada approval for Ondansetron 2mg / ml Injection; Supplies to commence in Q4 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Aug · Business
Press release dated August 06, 2007, titled "Strides Arcolab completes acquisition of Diaspa's USFDA approved fermentation facility in Italy". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
27 Jul · Business
Press release dated July 27, 2007, titled "Strides Arcolab registers 110% Increase in PAT in Q2 FY07; Revenues at Rs.180 crores". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jul · Business
Press release dated July 18, 2007, titled "Strides Arcolab receives its first injectable ANDA approval for Ketrolac Tromethamine USP, 15mg/mL and 30mg/mL". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
11 Jun · Business
Press release dated June 11, 2007, titled "Strides Arcolab completes acquisition of Indian Domestic Pharma Company - Grandix Pharmaceuticals Limited". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jun · Business
Press release dated June 07, 2007, titled "Strides Arcolab Limited Successfully Completes the US$ 100 million Convertible Bond Issue". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Jun · Business
Press release dated June 07, 2007, titled "Strides Arcolab Limited Announces the Launch of US$75 million Zero Coupon Convertible Bonds". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jun · Business
"Strides Arcolab Limited has received two more NDA approvals from US-FDA for fixed dose combination of: 1) Lamivudine/Stavudine 150 mg/40 mg tablets co-packaged with Efavirenz 600mg tablets And 2) Lamivudine/Zidovudine 150/300 mg tablets co-packaged with Efavirenz 600mg tablets". A copy of the press release dated June 06, 2007, titled "Strides Arcolab receives 2 more NDA approvals from US-FDA" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
29 May · Business
Press release dated May 29, 2007, titled "Strides Arcolab to acquire Diaspa's USFDA approved fermentation facility in Italy". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 May · Business
Press release dated May 25, 2007, titled "Strides Arcolab receives USFDA approval for its Sterile Facility in Bangalore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 May · Business
Press release dated May 11, 2007, titled "Strides' Brazilian unit Cellofarm Ltda. Inaugurates Sterile Antibiotics Facility". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 May · Business
Media release, dated May 02, 2007, titled "Strides Arcolab Limited & ACCU-BREAK Pharmaceuticals , INC. Terminate Joint Venture Agreement". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
26 Apr · Business
Press release dated April 26, 2007, titled "Strides Arcolab register 22% increase in consolidated revenue in Q1 FY07; Consolidated Revenues at Rs.1700 million; EBITDA at Rs.351 million; PBT at Rs.118 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2007
28 Mar · Business
Press release dated March 28, 2007, titled "Strides Arcolab receives ANDA approval from US-FDA for Efavirenz tablets". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Mar · Business
Press release dated March 14, 2007, titled "Strides Arcolab receives 2 NDA approvals from US-FDA; Total Approvals Reach 8". The copy of the press releases shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Mar · Business
Press releases dated March 05, 2007, titled "Strides Arcolab receives first NDA approval from USFDA". The details of the press releases shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2007
19 Feb · Business
Press release, dated February 19, 2007, titled "Strides Arcolab - Sterile Products Division Receives MHRA approval." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Feb · Business
Press release dated February 1, 2007, titled "JV of Strides Arcolab and Invent Farma of Iceland Acquires 100% Ownership of Farma Plus, Norway". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
30 Jan · Business
Press release, dated January 30, 2007, titled "Strides and Invent Farma Group froms a JVC for Spain and Portugal." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jan · Business
Press release, dated January 29, 2007, titled "Strides Arcolab FY 06 Global Revenues Grows 43% to Rs. 760 crores (US$ 170 million)." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.